Author Archives: Austin Angelo

H.C. Wainwright Reaffirms Their Buy Rating on Cytokinetics Inc (CYTK)

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Cytokinetics Inc (CYTK – Research Report), with a price target of $21. The company’s shares closed on Friday at $6.85. Pantginis said: “Our thesis is

Cantor Fitzgerald Reiterates a Buy Rating on TherapeuticsMD (TXMD)

Cantor Fitzgerald analyst Louise Chen reiterated a Buy rating on TherapeuticsMD (TXMD – Research Report) today and set a price target of $27. The company’s shares closed on Friday at $5.11. Chen observed: “We reiterate our OW rating. The execution

BMO Capital Remains a Hold on Gluskin Sheff + Assc (GS)

Gluskin Sheff + Assc (GS – Research Report), the Financial sector company, was revisited by a Wall Street analyst today. The company received a Hold rating from BMO Capital’s analyst Nik Priebe, with a C$10 price target. According to TipRanks.com,

ASGN Incorporated (ASGN) Gets a Buy Rating from BMO Capital

In a report issued on January 17, Jeffrey Silber from BMO Capital reiterated a Buy rating on ASGN Incorporated (ASGN – Research Report), with a price target of $77. The company’s shares closed on Friday at $62.08. According to TipRanks.com,

CIBC Reiterates a Hold Rating on TMAC Resources (TMR)

Yesterday, an analyst has provided a rating update for TMAC Resources (TMR – Research Report). Analyst Anita Soni from CIBC reiterated a Hold rating, with a C$6.50 price target. According to TipRanks.com, Soni has 0 stars on 0-5 star ranking

CIBC Reiterates a Hold Rating on HudBay Minerals (HBM)

The Materials sector company, HudBay Minerals (HBM – Research Report), has received a rating update from a Wall Street analyst yesterday. Analyst Oscar Cabrera from CIBC rated HudBay Minerals (HBM – Research Report) a Hold, setting a C$8 price target.